A randomized double-blind crossover trial comparing subthalamic and pallidal deep brain stimulation for dystonia

Area of Science:

• Neurology
• Neurosurgery
• Biomedical Engineering

Background:

• Dystonia is a movement disorder characterized by involuntary muscle contractions.
• Medically refractory dystonia presents significant challenges in treatment.
• Deep brain stimulation (DBS) offers a therapeutic option for movement disorders.

Purpose of the Study:

• To compare the efficacy and patient acceptance of subthalamic nucleus (STN) versus globus pallidus internus (GPi) as targets for DBS in patients with medically refractory dystonia.
• To evaluate the impact of STN and GPi stimulation on dystonia severity and quality of life.

Main Methods:

• A prospective, double-blind, crossover study involving 12 patients with dystonia.
• Bilateral implantation of electrodes in the STN and GPi.
• Patients received 6 months of stimulation in each target sequentially, with assessments using the Burke-Fahn-Marsden Dystonia Rating Scale (BFMDRS) and quality of life questionnaires.

Main Results:

• DBS significantly improved BFMDRS movement scores and quality of life in general.
• STN stimulation resulted in a greater average improvement in BFMDRS movement scores (13.8 points) compared to GPi stimulation (9.1 points).
• Patient acceptance was higher for STN stimulation (12/12 patients) than for GPi stimulation (7/12 patients).

Conclusions:

• The subthalamic nucleus (STN) appears to be a well-accepted and promising target for DBS in dystonia treatment.
• Further investigation is needed to determine the optimal DBS target for dystonia.
• Simultaneous stimulation of both the STN and GPi warrants further study for potential synergistic benefits.